PharVision Advisers’s General Motors GM Stock Holding History

PharVision Advisers’s Portfolio GM Stock Details GM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,471	Closed	-$201K	–	326
2025 Q4	$201K	Buy	+2,471	New	+$174K	0.1%	554

Other funds holding GM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

PharVision Advisers's GM Position: Q1 2026 in Review

PharVision Advisers sold out of General Motors (GM) in Q1 2026, closing a stake of 2,471 shares — an estimated $201K sold.

PharVision Advisers first reported a position in GM in Q4 2025 and held it in 1 quarter. The position peaked at $201K in Q4 2025. 1,512 funds tracked by Wall St. Rank hold GM as of Q1 2026.

PharVision Advisers reported no remaining General Motors position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 2,471 General Motors shares in Q1 2026, an estimated $201K.
PharVision Advisers first reported a position in General Motors in Q4 2025 and held it in 1 quarter.
PharVision Advisers's General Motors position peaked at $201K in Q4 2025.
1,512 funds tracked by Wall St. Rank held General Motors as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.